These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38296485)

  • 1. A 70-year-old Woman with Asymptomatic Ferroportin Disease.
    Ishikawa T; Tatsumi Y; Kato K; Hayashi Y; Imai N; Ito T; Ishizu Y; Ishigami M; Nihei W; Kato A; Hayashi H
    Intern Med; 2024 Sep; 63(17):2421-2425. PubMed ID: 38296485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
    Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
    Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease].
    Ohara K; Tsuge N; Watanabe S; Eda H; Ogasawara F; Kondo T; Yoshida S; Kojima K
    Rinsho Ketsueki; 2023; 64(11):1410-1414. PubMed ID: 38072426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
    Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
    J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
    Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
    BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
    Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
    Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
    Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
    Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Mutations by Targeted NGS Panel in Patients with Hyperferritinemia.
    Ravasi G; Pelucchi S; Bertola F; Capelletti MM; Mariani R; Piperno A
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism.
    Honma Y; Karasuyama T; Kumamoto K; Shimajiri S; Toki Y; Tatsumi Y; Sumida K; Koikawa K; Morino K; Oe S; Miyagawa K; Yamasaki M; Shibata M; Abe S; Ikuta K; Hayashi H; Harada M
    Med Mol Morphol; 2021 Mar; 54(1):60-67. PubMed ID: 32607777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of hepcidin levels in a patient with G80S-linked ferroportin disease undergoing iron depletion by phlebotomy.
    Wolff F; Bailly B; Gulbis B; Cotton F
    Clin Chim Acta; 2014 Mar; 430():20-1. PubMed ID: 24370385
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
    Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
    Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign.
    Hayashi H; Yano M; Urawa N; Mizutani A; Hamaoka S; Araki J; Kojima Y; Naito Y; Kato A; Tatsumi Y; Kato K
    Intern Med; 2018 Oct; 57(19):2865-2871. PubMed ID: 29780118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature.
    Zhang W; Lv T; Huang J; Ou X
    Medicine (Baltimore); 2017 Sep; 96(38):e8064. PubMed ID: 28930842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease.
    Lefebvre T; Reihani N; Daher R; de Villemeur TB; Belmatoug N; Rose C; Colin-Aronovicz Y; Puy H; Le Van Kim C; Franco M; Karim Z
    Haematologica; 2018 Apr; 103(4):587-596. PubMed ID: 29305416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the molecular basis of ferroportin resistance to hepcidin: Structure/function analysis of rare SLC40A1 missense mutations found in suspected hemochromatosis type 4 patients.
    Le Tertre M; Ka C; Guellec J; Gourlaouen I; Férec C; Callebaut I; Le Gac G
    Transfus Clin Biol; 2017 Nov; 24(4):462-467. PubMed ID: 28826751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of ferroportin-linked hemochromatosis.
    De Domenico I; Ward DM; Nemeth E; Vaughn MB; Musci G; Ganz T; Kaplan J
    Proc Natl Acad Sci U S A; 2005 Jun; 102(25):8955-60. PubMed ID: 15956209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.
    Pietrangelo A
    Gastroenterology; 2015 Oct; 149(5):1240-1251.e4. PubMed ID: 26164493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.